Literature DB >> 16239396

Dendritic cells: potential triggers of autoimmunity and targets for therapy.

J A Hardin1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16239396      PMCID： PMC1766899          DOI： 10.1136/ard.2005.044560

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  75 in total

Review 1.  Anti-malarial drugs: possible mechanisms of action in autoimmune disease and prospects for drug development.

Authors:  R Fox
Journal:  Lupus       Date:  1996-06       Impact factor: 2.911

Review 2.  Clinical relevance of autoantibodies in systemic rheumatic diseases.

Authors:  M J Fritzler
Journal:  Mol Biol Rep       Date:  1996       Impact factor: 2.316

3.  The cytokine profile expressed by human dendritic cells is dependent on cell subtype and mode of activation.

Authors:  B de Saint-Vis; I Fugier-Vivier; C Massacrier; C Gaillard; B Vanbervliet; S Aït-Yahia; J Banchereau; Y J Liu; S Lebecque; C Caux
Journal:  J Immunol       Date:  1998-02-15       Impact factor: 5.422

4.  Reduced serum 1,25-(OH)2 vitamin D3 levels in prednisone-treated adolescents with systemic lupus erythematosus.

Authors:  S O'Regan; R W Chesney; A Hamstra; J A Eisman; A M O'Gorman; H F Deluca
Journal:  Acta Paediatr Scand       Date:  1979-01

Review 5.  Mechanism of action of antimalarial drugs: inhibition of antigen processing and presentation.

Authors:  R I Fox; H I Kang
Journal:  Lupus       Date:  1993-02       Impact factor: 2.911

6.  Dendritic cells in cutaneous lupus erythematosus: a clue to the pathogenesis of lesions.

Authors:  M Mori; N Pimpinelli; P Romagnoli; E Bernacchi; P Fabbri; B Giannotti
Journal:  Histopathology       Date:  1994-04       Impact factor: 5.087

7.  Glucocorticoids down-regulate dendritic cell function in vitro and in vivo.

Authors:  M Moser; T De Smedt; T Sornasse; F Tielemans; A A Chentoufi; E Muraille; M Van Mechelen; J Urbain; O Leo
Journal:  Eur J Immunol       Date:  1995-10       Impact factor: 5.532

8.  1,25-Dihydroxyvitamin D3 inhibits antigen-induced T cell activation.

Authors:  A K Bhalla; E P Amento; B Serog; L H Glimcher
Journal:  J Immunol       Date:  1984-10       Impact factor: 5.422

9.  Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha.

Authors:  F Sallusto; A Lanzavecchia
Journal:  J Exp Med       Date:  1994-04-01       Impact factor: 14.307

10.  Dendritic cells pulsed with protein antigens in vitro can prime antigen-specific, MHC-restricted T cells in situ.

Authors:  K Inaba; J P Metlay; M T Crowley; R M Steinman
Journal:  J Exp Med       Date:  1990-08-01       Impact factor: 14.307
View more
  10 in total

Review 1.  Dendritic cells and aging: consequences for autoimmunity.

Authors:  Anshu Agrawal; Aishwarya Sridharan; Sangeetha Prakash; Harsh Agrawal
Journal:  Expert Rev Clin Immunol       Date:  2012-01       Impact factor: 4.473

Review 2.  Potential applications of nanoparticles in cancer immunotherapy.

Authors:  Yimei Jia; Abdelwahab Omri; Lakshmi Krishnan; Michael J McCluskie
Journal:  Hum Vaccin Immunother       Date:  2016-11-21       Impact factor: 3.452

Review 3.  The role of dendritic cells in multiple sclerosis.

Authors:  Gregory F Wu; Terri M Laufer
Journal:  Curr Neurol Neurosci Rep       Date:  2007-05       Impact factor: 5.081

4.  Regulatory T cells induced by GM-CSF suppress ongoing experimental myasthenia gravis.

Authors:  Jian Rong Sheng; Liang Cheng Li; Balaji B Ganesh; Bellur S Prabhakar; Matthew N Meriggioli
Journal:  Clin Immunol       Date:  2008-05-27       Impact factor: 3.969

Review 5.  Vitamin D and autoimmunity: new aetiological and therapeutic considerations.

Authors:  Yoav Arnson; Howard Amital; Yehuda Shoenfeld
Journal:  Ann Rheum Dis       Date:  2007-06-08       Impact factor: 19.103

6.  Reduced number and function of peripheral dendritic cells in coeliac disease.

Authors:  R Ciccocioppo; G Ricci; B Rovati; I Pesce; S Mazzocchi; D Piancatelli; A Cagnoni; D Millimaggi; M Danova; G R Corazza
Journal:  Clin Exp Immunol       Date:  2007-06-20       Impact factor: 4.330

Review 7.  Autoimmunological features in inflammatory cardiomyopathy.

Authors:  Angela Kallwellis-Opara; Andrea Dörner; Wolfgang-Christian Poller; Michel Noutsias; Uwe Kühl; Heinz-Peter Schultheiss; Mathias Pauschinger
Journal:  Clin Res Cardiol       Date:  2007-05-22       Impact factor: 5.460

8.  Preliminary evaluation in rheumatoid arthritis activity in patients treated with TNF-alpha blocker plus methotrexate versus methotrexate or leflunomide alone.

Authors:  Margaret Wisłowska; Danuta Jakubicz
Journal:  Rheumatol Int       Date:  2007-01-18       Impact factor: 3.580

9.  Involvement of dendritic cells in autoimmune diseases in children.

Authors:  Consuelo M López de Padilla; Ann M Reed
Journal:  Pediatr Rheumatol Online J       Date:  2007-07-11       Impact factor: 3.054

10.  TSP1-producing B cells show immune regulatory property and suppress allergy-related mucosal inflammation.

Authors:  Huan-Ping Zhang; Yingying Wu; Jiangqi Liu; Jing Jiang; Xiao-Rui Geng; Gui Yang; Lihua Mo; Zhi-Qiang Liu; Zhi-Gang Liu; Ping-Chang Yang
Journal:  Sci Rep       Date:  2013-11-26       Impact factor: 4.379
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.